Antiarrhythmic Treatment of Atrial Arrhythmias

  title={Antiarrhythmic Treatment of Atrial Arrhythmias},
  author={H. Kulbertus},
  journal={Journal of Cardiovascular Pharmacology},
  • H. Kulbertus
  • Published 1991
  • Medicine
  • Journal of Cardiovascular Pharmacology
Summary: Atrial premature beats seldom require an antiarrhythmic treatment; reassurance and suppression of coffee, alcohol, and tobacco generally suffice. Acute atrial fibrillation is best treated by electrical cardioversion if it induces acute cardiovascular decompensation. If it is not poorly tolerated, the arrhythmia may be treated with digitalis at doses sufficient to keep the ventricular response rate at 70–90/min. This therapy may restore sinus rhythm, but conversion to sinus rhythm often… Expand
21 Citations
Clinical course of recent-onset atrial fibrillation treated with oral propafenone.
The prognosis for conversion to sinus rhythm within 48 h, with propafenone, is excellent (87 percent) and safe and with respect to cause of AF, all groups showed a high incidence of conversion. Expand
Newer developments in the management of atrial fibrillation.
New developments in the management of AF are focused on, including prospects for improved methods to maintain sinus rhythm, newer approaches to rate control, controversies regarding the use of oral anticoagulation, and novel nonpharmacologic therapies. Expand
Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (RAF): An Emergency Medicine External Validity Study.
In "real life emergency medicine," esmolol is better than amiodarone in the treatment of RAF and for all indicators from 10 to 120 min after treatment onset. Expand
Atrial fibrillation: maintaining the sinus rhythm
The most important concern with atrial fibrillation relates to its embolic manifestations that, in 75% of instances, result in cerebrovascular accidents. Expand
Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation.
Remodeling of atrial size and emptying function is much greater in HF than in ATR, and structural remodeling appears much more important in HF-induced AF. Expand
New Approaches to Treatment of Atrial Flutter and Tachycardia
The purpose of this article is to reviewed the current understanding of the pathophysiology of atrial tachycardia and flutter and in particular to review the options available for therapeutic intervention. Expand
Prevention of left ventricular hypertrophy by ACE-inhibitor, ramipril in comparison with calcium-channel antagonist, felodipine.
Two anti-hypertensive drugs reduce systemic hypertension the same way, but, in hypertensives receiving ramipril, the echocardiographic parameters of the left ventricle increased non-significantly and in those treated with felodipine, these parameters significantly changed. Expand
Characteristics of the delayed rectifier K current compared in myocytes isolated from the atrioventricular node and ventricle of the rabbit heart
The faster deactivation ofIK in AVn cells was a distinguishing feature and suggests that there may be differences in theIKr channel protein between ventricular and AVN cells. Expand
Effects of Azimilide Dihydrochloride on Circus Movement Atrial Flutter in the Canine Sterile Pericarditis Model
The effects of a Class III agent, azimilide di‐hydrochloride, on atrial flutter circuits were studied in a functional model of single loop reentrant atrial Flutter using dogs, 3 to 5 days after production of sterile pericarditis. Expand
Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine.
  • C. Conti
  • Medicine
  • The American journal of cardiology
  • 1996
Evidence and clinical practice strongly support a major role for these drugs in the management of many cardiovascular diseases such as arrhythmia, vascular spasm, hypertension, diastolic dysfunction, stable angina, and myocardial infarction. Expand